If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


 
LION FUND II, L.P.
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Chairman and Chief Executive Officer of Biglari Capital Corp., its general partner
Date:05/29/2025
 
BIGLARI CAPITAL CORP.
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Chairman and Chief Executive Officer
Date:05/29/2025
 
First Guard Insurance Company
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Authorized Signatory
Date:05/29/2025
 
Southern Pioneer Property and Casualty Insurance Company
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Authorized Signatory
Date:05/29/2025
 
Biglari Reinsurance Ltd.
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Chairman and Chief Executive Officer
Date:05/29/2025
 
Biglari Insurance Group Inc.
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Chairman of the Board
Date:05/29/2025
 
Biglari Holdings Inc.
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari, Chairman and Chief Executive Officer
Date:05/29/2025
 
BIGLARI, SARDAR
 
Signature:/s/ Sardar Biglari
Name/Title:Sardar Biglari
Date:05/29/2025

Exhibit 1

Transactions in Shares Since the Filing of Amendment No. 57 to the Schedule 13D

Nature of the Transaction

Securities

Purchased/(Sold)

Price Per

Share($)

Date of

Purchase / Sale

 

THE LION FUND II, L.P.

Sale of Common Stock1 (61,924) 56.06 05/22/2025
Sale of Common Stock2 (202,153) 58.70 05/27/2025
Sale of Common Stock3 (26,500) 59.37 05/28/2025
Sale of Common Stock4 (50,104) 58.91 05/29/2025

 

1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.25 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.24 to $59.36 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.01 to $59.97 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.36 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.